Using this assay, we show that IL-19 levels are dramatically elevated in psoriasis, genital psoriasis, and psoriatic arthritis, are highly correlated with skin involvement, and function as a leading indicator of skin disease severity during treatment with multiple classes of medications. This evidence concerns the gene IL19 and psoriatic arthritis.